Fingolimod is associated with a 0.5–0.6% of macular edema, usually presenting ... while CN III and CN IV palsies are seen very rarely in MS. Other eye movement abnormalities which may occur ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

Figure 2 provides a birds-eye view of the current and future trends in the management of severe OSD. Current management may not completely restore the functions and structure of the ocular surface ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

An announcement from Opthea Limited ( (AU:OPT) ) is now available.

Macular neovascularization within 1 year of avacincaptad pegol therapy worsens outcomes compared with patients without ...

Omega-3 polyunsaturated fatty acids and docosahexaenoic acid appear to be associated with lower age-related macular ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...